US Neurodegenerative Disease Market Segment – Therapeutic Class Insights The US Neurodegenerative Disease Market segment analysis categorizes therapies into disease-modifying drugs, symptomatic treatments, combination therapies, and supportive care. Disease-modifying treatments, including gene therapies and monoclonal antibodies, are increasingly adopted for their ability to slow disease progression. Symptomatic treatments continue to manage motor and cognitive...
0 Compartilhamentos
129 Visualizações